Skip to content
  • CMO Login
  • Collaborators Login
  • Home
  • Who We Are
    • About Us
  • What We Do
    • Programs & Services
    • Technologies
  • BioIntelligence
  • News
    • Press Releases
    • Publications
    • Events
  • Contact Us

Press Releases

September 14, 2020 | Business Wire

Cerveau Technologies, Inc. announces Formation of Scientific Advisory Board

Cerveau Technologies, Inc. today announced formation of its Scientific Advisory Board (SAB), comprised of top tier...

September 9, 2020 | SAB virtual conference

Cerveau Scientific Advisory Board Virtual Conference 2020

MK-6240 Users Group Meeting | Webinar #1 by Cerveau Technologies Inc 2020 Virtual Conference with world...

May 4, 2020 | Business Wire

Cerveau Technologies, Inc. Announces Collaboration with University College of London

BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced a research collaboration with University College London (UCL), a leading...

March 20, 2020 | Business Wire

Cerveau Technologies, Inc. Announces Collaboration with Alector, Inc.

BOSTON–(BUSINESS WIRE)–Cerveau Technologies Inc. today announced a licensing agreement with Alector, in which Cerveau will provide...

December 1, 2019 | Business Wire

Enigma Biomedical Group Announces Appointment of Michael Reitermann to Their Board of Directors

TORONTO–(BUSINESS WIRE)–Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of...

November 14, 2019 | Business Wire

Cerveau Technologies, Inc. Announces Initiation of Japanese Phase I Study

KNOXVILLE, Tennessee--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced that the first healthy volunteer was injected and scanned...

September 27, 2019 | Business Wire

Cerveau Technologies Inc. Signs Research Agreement with Takeda to Provide Novel Tau Imaging Agent

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda),...

May 19, 2019 | Business Wire

Cerveau Technologies, Inc. Announces a Partnership with LuMind IDSC Foundation to Study Accumulation of Neurofibrillary Tau in Down Syndrome

BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration with the LuMind IDSC Foundation (LuMind IDSC)...

March 22, 2019 | Business Wire

Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent

BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable...

Next »

308 N. Peters Road Suite #201
Knoxville, TN 37922

(865) 868-3402

info@cerveautechnologies.com

© Copyright 2021 Cerveau Technologies. All Rights Reserved.

Technology Web Design by Thomas Digital

  • Home
  • Who We Are
    • About Us
  • What We Do
    • Programs & Services
    • Technologies
  • BioIntelligence
  • News
    • Press Releases
    • Publications
    • Events
  • Contact Us